SCHEMBL29932967

SCHEMBL29932967

Cc1ccc(C(=O)N[C@H]2CCCC[C@@H]2O)cc1OCc1cncc(-c2ncccn2)c1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 6/20 0.49
▸ GABRA5 P31644 10/20 0.44
▸ DGAT2 Q96PD7 2/20 0.41
▸ GABRA1 P14867 2/20 0.41
▸ TACR2 P21452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29933427 0.91 CNR1 (0.54) CNR1GABRA5GABRA1TACR2
SCHEMBL29933301 0.90 CNR1 (0.53) CNR1TACR2
SCHEMBL29935081 0.84 DDR1 (0.44) CNR1GABRA5
SCHEMBL29933144 0.83 CNR1 (0.44) CNR1GABRA5DGAT2TACR2
SCHEMBL29933042 0.82 CNR1 (0.46) CNR1GABRA5DGAT2
SCHEMBL28884716 0.81 RXRA (0.48) —
SCHEMBL29934080 0.81 RXRA (0.48) —
SCHEMBL28884605 0.79 MAPT (0.46) —
SCHEMBL29932952 0.79 CNR1 (0.42) CNR1GABRA5TACR2
SCHEMBL29932961 0.79 CNR1 (0.42) CNR1GABRA5TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119371371-A Compounds and compositions as PDGF receptor kinase inhibitors 日本新药株式会社 2025-01-28 — — CN claimed
CN-115315421-A Compounds and compositions as PDGF receptor kinase inhibitors 日本新药株式会社 2022-11-08 — — CN claimed
CN-119371371-A Compounds and compositions as PDGF receptor kinase inhibitors 日本新药株式会社 2025-01-28 — — CN disclosed
CN-115315421-B Compounds and compositions as PDGF receptor kinase inhibitors 日本新药株式会社 2024-12-03 — — CN disclosed
CN-115315421-A Compounds and compositions as PDGF receptor kinase inhibitors 日本新药株式会社 2022-11-08 — — CN disclosed
Send feedback